Streamex Corp

Streamex’s insider buy signals confidence in its cutting‑edge catheter ablation tech and rising reimbursement upside, offering a high‑growth, risk‑tolerant play for investors.

Insider buying spurs optimism for Streamex Corp., with CFO awarding 500k RSUs at $1.14/unit—signals confidence in a rebound after tax relief and a robust tech pipeline.

Insider buying fuels optimism for Streamex Corp’s tokenized supply platform—clinical safety, 15% efficiency gains, and pending FDA clearance could spark a rally.

Insider buy by GIUSTRA FRANK at $3.00 shows confidence in Streamex Corp., a growing digital‑media player with a $35 M raise, strong 2025 results and AI‑powered growth, but with high risk and volatile market dynamics.

Insider buying at Streamex Corp. shows confidence after a $35M public offer—yet the company’s negative earnings, high volatility, and FDA hurdles remain key risk factors.

Insider Lekstrom Morgan Lee buys 23k Streamex shares at $3.30 after its $35M IPO, signaling confidence in the company’s high‑growth cardiac tech pipeline.

Insider buying at Streamex Corp. shows management confidence amid volatility, signaling potential upside after a 12.9% monthly rally and liquidity moves.